Aimfinity Investment Corp. and Docter Inc. Complete Business Combination
Wilmington, DE, March 28, 2025 – Aimfinity Investment Corp. I (Nasdaq: AIMAU) (the “Company” or “AIMA”), a special purpose acquisition company, is pleased to announce the successful completion of its business combination (the “Business Combination”) with Docter Inc. (“Docter”), a leading health technology company based in Taiwan. The combination was approved at an extraordinary general meeting of shareholders (the “EGM”) of AIMA, which was held on March 27, 2025.
Shareholder Approval
Approximately 93.8% of the votes cast at the EGM were in favor of the Business Combination. The remaining shares were withheld or abstained from voting. The approval of the Business Combination by AIMA’s shareholders follows the unanimous recommendation of the Special Committee of the Board of Directors of AIMA, which was formed to oversee the transaction process.
Docter Inc. Overview
Docter is a health technology company that provides a comprehensive suite of telemedicine and digital health solutions in Taiwan. The company’s platform offers online consultations, prescription services, and health management tools, making healthcare more accessible and convenient for consumers. Docter has a strong presence in the Taiwanese market, with over 3,000 affiliated doctors and 15 million registered users.
Impact on AIMA and Docter
The Business Combination will provide Docter with the capital and resources needed to expand its operations and further develop its technology platform. AIMA will become a publicly-traded company through this transaction and will benefit from the growth potential of Docter. The combined entity will be named Docter Inc. and is expected to begin trading on the Nasdaq under the symbol “DOCT” following the completion of the transaction.
Effect on Consumers
- Improved access to healthcare services: With the integration of Docter’s telemedicine platform into AIMA’s resources, consumers in Taiwan and potentially other markets will have easier access to healthcare services.
- Enhanced digital health solutions: The Business Combination will enable Docter to invest in the development of new digital health tools and services, improving the overall user experience.
- Expanded reach: Docter’s presence in the Taiwanese market will be strengthened, allowing the company to reach more consumers and grow its user base.
Effect on the World
The Business Combination between AIMA and Docter represents a significant step forward in the integration of technology into the healthcare industry. As telemedicine and digital health solutions become increasingly important, this transaction demonstrates the potential for companies to collaborate and leverage each other’s strengths to drive innovation and growth.
Conclusion
The completion of the Business Combination between Aimfinity Investment Corp. I and Docter Inc. marks a milestone in the healthcare technology sector. With the approval of AIMA’s shareholders, the combined entity is poised to expand its operations and further develop its technology platform. The impact on consumers, through improved access to healthcare services and enhanced digital health solutions, is expected to be significant. The transaction also serves as a reminder of the potential for collaboration and innovation in the technology and healthcare industries.
For more information about Docter Inc. and the Business Combination, please visit the Company’s website at
